Health TrialsbyHealthPanel

Study of Treatment of Thoracic Aortic Aneurysms and Dilatation in Combination With Tricuspid and Bicuspid Aortic Valves.

ConditionsAscending Aorta AneurysmDilation of the Ascending Aorta
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45-75
SponsorTomsk National Research Medical Center of the Russian Academy of Sciences

About this trial

Clarification of indications for surgical correction in patients with borderline expansion of the ascending aorta

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Extension of the ascending aorta less than 55 mm

Tricuspid Aortic Valves.

Extension of the ascending aorta more than 45 mm

Disqualifiers

Age less 45 years

Age more 75 years

Multiple organ failure

oncological disease

Trial population

Patients with computed tomography-diagnosed ascending aortic dilation greater than 45 mm, less than 55 mm with tricuspid aortic valve compared to patients with bicuspid aortic valve and healthy volunteers

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • aortic prosthetics

    Other intervention

    aortic prosthetics

Treatment groups

80 Participants
are divided into 3 treatment groups
Group A: healthy1 intervention
Group B: ascending aortic dilation 45-55, operated on1 intervention
Group C: ascending aortic dilation 45-55, non operated on1 intervention

Trial outcomes

Primary outcomes

1

death

death

Time frame
30 day after operation
2

aorto-associated complications

rupture, dissection

Time frame
30 day

Secondary outcomes

1

increasing the diameter of the ascending aorta

increasing the diameter of the ascending aorta more than 55 mm

Time frame
1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tomsk National Research Medical Center of the Russian Academy of Sciences

Lead sponsor

Source ClinicalTrials.gov
Apply now